The role of IFN-γ is well-established in the induction of a protective effect against clinical and experimental HNSCC [40,41], and CD8+ T-cells are known to produce and become activated by this cytokine [42]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.